EU and Industry Join Forces to Invest €22 Billion in Research and Innovation

The European Commission, EU Member States and European industry will invest more than €22 billion over the next seven years in innovation for sectors that deliver high quality jobs. Most of the investment will go to five public-private partnerships in innovative medicines, aeronautics, bio-based industries, fuel cells and hydrogen, and electronics. These research partnerships will boost the competitiveness of EU industry in sectors that already provide more than 4 million jobs. They will also find solutions to major challenges for society that are not being solved quickly enough by the market alone, such as reducing carbon emissions or providing the next generation of antibiotics. The package also proposes to extend an initiative to pool research and innovation investments in Air Traffic Management (SESAR), in support of the Single European Sky.

José Manuel Barroso, President of the European Commission, said: "The EU must remain a leader in strategic global technology sectors that provide high quality jobs. This innovation investment package combines public and private funding to do just that. This is a perfect demonstration of the leverage effect of the EU budget for growth and jobs."

Overall, a proposed €8 billion investment from the next EU research and innovation programme, Horizon 2020, will secure around €10 billion from industry, and close to €4 billion from EU Member States.

European Commissioner for Research, Innovation and Science Máire Geoghegan-Quinn said: "These initiatives not only strengthen our economy, they are an investment in a better quality of life. Working together will enable us to tackle issues that no one company or country can deal with alone."

The five Public-Private Partnerships, called 'Joint Technology Initiatives' (JTIs), are:

  • Innovative Medicines 2 (IMI2): to develop next generation vaccines, medicines and treatments, such as new antibiotics
  • Fuel Cells and Hydrogen 2 (FCH2): to expand the use of clean and efficient technologies in transport, industry and energy
  • Clean Sky 2 (CS2): to develop cleaner, quieter aircraft with significantly less CO2 emissions
  • Bio-based Industries (BBI): to use renewable natural resources and innovative technologies for greener everyday products
  • Electronic Components and Systems (ECSEL): to boost Europe’s electronics manufacturing capabilities

The JTIs are open to a wide range of industries across Europe, including SMEs, and all types of research organisations can apply for funding. The Commission has developed the new initiatives in close partnership with industry, who in turn have committed substantial financial resources. Major changes have been introduced to address the criticisms that the current initiatives are overly complex and difficult to participate in.

The Innovative Medicines Initiative, Clean Sky and Fuel Cells and Hydrogen JTIs all currently exist, while the Electronics JTI will combine two current partnerships. The Bio-based Industries JTI is a new initiative. New legislative proposals are needed now to establish the initiatives under the next EU research and innovation programme, Horizon 2020, which is subject to approval by the European Parliament and Council.

The package also includes four public-public partnerships between the European Commission and EU Member States: new treatments against poverty-related diseases, measurement technologies for industrial competitiveness, support for high tech SMEs, and solutions for the elderly and disabled to live safely in their homes.

The Commission Communication accompanying the legislative proposals also sets out how the Commission intends to strengthen industrial engagement in Horizon 2020 through further public-private partnerships, such as in the areas of Green Cars, Energy Efficient Buildings, Factories of the Future, Sustainable Process Industries, Robotics and Photonics.

Most Popular Now

When it comes to Emergency Care, ChatGPT…

If ChatGPT were cut loose in the Emergency Department, it might suggest unneeded x-rays and antibiotics for some patients and admit others who didn't require hospital treatment, a new study...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

Why the NHS is Seeking to Make Media Ser…

Opinion Article by Dean Moody, Healthcare Services Director, Airwave Healthcare. Tim Kelsey and Martha Lane Fox called for WiFi to be made available free of charge throughout the NHS back in...

An AI-Powered Pipeline for Personalized …

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses...

Commission Joins Forces with Venture Cap…

The Commission has launched a Trusted Investors Network bringing together a group of investors ready to co-invest in innovative deep-tech companies in Europe together with the EU. The Union's investment...

AI could Transform How Hospitals Produce…

A pilot study led by researchers at University of California San Diego School of Medicine found that advanced artificial intelligence (AI) could potentially lead to easier, faster and more efficient...

Great Start for Ideas and Innovations: D…

8 - 10 April 2025, Berlin, Germany. From 15 October to 15 November 2024, the DMEA invites experts from business, science, politics and practice to actively participate in shaping the congress...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...